세계의 과민성 대장증후군 (IBS) 시장예측 2021년-2026년

■ 영문 제목 : Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K00075 입니다.■ 상품코드 : LPI-2201K00075
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 87
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료, 제약
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,941,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩7,411,500견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩9,882,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 과민성 대장증후군 (IBS)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (IBS-D 약, IBS-C 약, 기타)와 용도별 시장규모 (여성, 남성) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 과민성 대장증후군 (IBS) 시장 점유율
- 지역별 과민성 대장증후군 (IBS) 시장규모
- 주요지역의 종류별 시장규모 (IBS-D 약, IBS-C 약, 기타)
- 주요지역의 용도별 시장규모 (여성, 남성)
- 미주의 과민성 대장증후군 (IBS) 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 과민성 대장증후군 (IBS) 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 과민성 대장증후군 (IBS) 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 과민성 대장증후군 (IBS) 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 과민성 대장증후군 (IBS) 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Irritable Bowel Syndrome (IBS) will have significant change from previous year. By the most conservative estimates of global Irritable Bowel Syndrome (IBS) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4041 million in 2020. Over the next five years the Irritable Bowel Syndrome (IBS) market will register a 15.6% CAGR in terms of revenue, the global market size will reach US$ 7206.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
IBS-D Drug
IBS-C Drug
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Women
Men

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size 2016-2026
2.1.2 Irritable Bowel Syndrome (IBS) Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-D Drug
2.2.3 Others
2.3 Irritable Bowel Syndrome (IBS) Market Size by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Market Size CAGR by Type
2.3.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2016-2021)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Market Size by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Market Size CAGR by Application
2.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2016-2021)

3 Irritable Bowel Syndrome (IBS) Market Size by Players
3.1 Irritable Bowel Syndrome (IBS) Market Size Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2019-2021E)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2019-2021E)
3.2 Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) Market Size by Regions (2016-2021)
4.2 Americas Irritable Bowel Syndrome (IBS) Market Size Growth (2016-2021)
4.3 APAC Irritable Bowel Syndrome (IBS) Market Size Growth (2016-2021)
4.4 Europe Irritable Bowel Syndrome (IBS) Market Size Growth (2016-2021)
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth (2016-2021)

5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
5.2 Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
5.3 Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021)
6.2 APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
6.3 APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Country (2016-2021)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Region (2016-2021)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Irritable Bowel Syndrome (IBS) Market Forecast
10.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2021-2026)
10.1.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2021-2026)
10.1.2 Americas Irritable Bowel Syndrome (IBS) Forecast
10.1.3 APAC Irritable Bowel Syndrome (IBS) Forecast
10.1.4 Europe Irritable Bowel Syndrome (IBS) Forecast
10.1.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Forecast
10.2 Americas Irritable Bowel Syndrome (IBS) Forecast by Countries (2021-2026)
10.2.1 United States Irritable Bowel Syndrome (IBS) Market Forecast
10.2.2 Canada Irritable Bowel Syndrome (IBS) Market Forecast
10.2.3 Mexico Irritable Bowel Syndrome (IBS) Market Forecast
10.2.4 Brazil Irritable Bowel Syndrome (IBS) Market Forecast
10.3 APAC Irritable Bowel Syndrome (IBS) Forecast by Region (2021-2026)
10.3.1 China Irritable Bowel Syndrome (IBS) Market Forecast
10.3.2 Japan Irritable Bowel Syndrome (IBS) Market Forecast
10.3.3 Korea Irritable Bowel Syndrome (IBS) Market Forecast
10.3.4 Southeast Asia Irritable Bowel Syndrome (IBS) Market Forecast
10.3.5 India Irritable Bowel Syndrome (IBS) Market Forecast
10.3.6 Australia Irritable Bowel Syndrome (IBS) Market Forecast
10.4 Europe Irritable Bowel Syndrome (IBS) Forecast by Country (2021-2026)
10.4.1 Germany Irritable Bowel Syndrome (IBS) Market Forecast
10.4.2 France Irritable Bowel Syndrome (IBS) Market Forecast
10.4.3 UK Irritable Bowel Syndrome (IBS) Market Forecast
10.4.4 Italy Irritable Bowel Syndrome (IBS) Market Forecast
10.4.5 Russia Irritable Bowel Syndrome (IBS) Market Forecast
10.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Forecast by Region (2021-2026)
10.5.1 Egypt Irritable Bowel Syndrome (IBS) Market Forecast
10.5.2 South Africa Irritable Bowel Syndrome (IBS) Market Forecast
10.5.3 Israel Irritable Bowel Syndrome (IBS) Market Forecast
10.5.4 Turkey Irritable Bowel Syndrome (IBS) Market Forecast
10.5.5 GCC Countries Irritable Bowel Syndrome (IBS) Market Forecast
10.6 Global Irritable Bowel Syndrome (IBS) Forecast by Type (2021-2026)
10.7 Global Irritable Bowel Syndrome (IBS) Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Bausch Health
11.1.1 Bausch Health Company Information
11.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Bausch Health Main Business Overview
11.1.5 Bausch Health Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Offered
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Offered
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Information
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Main Business Overview
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Information
11.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Sebela Pharmaceuticals Inc Main Business Overview
11.5.5 Sebela Pharmaceuticals Inc Latest Developments
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Information
11.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Astellas Pharmaceuticals Main Business Overview
11.6.5 Astellas Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Irritable Bowel Syndrome (IBS) Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of IBS-D Drug
Table 3. Major Players of IBS-C Drug
Table 4. Major Players of Others
Table 5. Irritable Bowel Syndrome (IBS) Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2016-2021)
Table 8. Irritable Bowel Syndrome (IBS) Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2016-2021)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2019-2021E)
Table 13. Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
Table 14. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Irritable Bowel Syndrome (IBS) Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions 2016-2021
Table 19. Americas Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Country (2016-2021)
Table 21. Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2016-2021)
Table 23. Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2016-2021)
Table 25. APAC Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2016-2021)
Table 27. APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2016-2021)
Table 29. APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2016-2021)
Table 31. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Country (2016-2021)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2016-2021)
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Irritable Bowel Syndrome (IBS)
Table 44. Key Application and Potential Industries of Irritable Bowel Syndrome (IBS)
Table 45. Key Challenges of Irritable Bowel Syndrome (IBS)
Table 46. Key Trends of Irritable Bowel Syndrome (IBS)
Table 47. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Application (2021-2026)
Table 53. Bausch Health Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 54. Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
Table 55. Bausch Health Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Bausch Health Main Business
Table 57. Bausch Health Latest Developments
Table 58. Allergan Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 59. Allergan Irritable Bowel Syndrome (IBS) Product Offered
Table 60. Allergan Main Business
Table 61. Allergan Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Allergan Latest Developments
Table 63. Takeda Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 64. Takeda Irritable Bowel Syndrome (IBS) Product Offered
Table 65. Takeda Main Business
Table 66. Takeda Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Takeda Latest Developments
Table 68. Sucampo Pharmaceuticals (Mallinckrodt) Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 69. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
Table 70. Sucampo Pharmaceuticals (Mallinckrodt) Main Business
Table 71. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
Table 73. Sebela Pharmaceuticals Inc Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 74. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
Table 75. Sebela Pharmaceuticals Inc Main Business
Table 76. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Sebela Pharmaceuticals Inc Latest Developments
Table 78. Astellas Pharmaceuticals Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 79. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 80. Astellas Pharmaceuticals Main Business
Table 81. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Astellas Pharmaceuticals Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2020
Figure 7. Irritable Bowel Syndrome (IBS) in Women
Figure 8. Global Irritable Bowel Syndrome (IBS) Market: Women (2016-2021) & ($ Millions)
Figure 9. Irritable Bowel Syndrome (IBS) in Men
Figure 10. Global Irritable Bowel Syndrome (IBS) Market: Men (2016-2021) & ($ Millions)
Figure 11. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2020
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Player in 2020
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Irritable Bowel Syndrome (IBS) Market Size 2016-2021 ($ Millions)
Figure 15. APAC Irritable Bowel Syndrome (IBS) Market Size 2016-2021 ($ Millions)
Figure 16. Europe Irritable Bowel Syndrome (IBS) Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2016-2021 ($ Millions)
Figure 18. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Country in 2020
Figure 19. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2020
Figure 20. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2020
Figure 21. United States Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions in 2020
Figure 25. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2020
Figure 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2020
Figure 27. China Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Country in 2020
Figure 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2020
Figure 35. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2020
Figure 36. Germany Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2020
Figure 44. Egypt Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Irritable Bowel Syndrome (IBS) Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 50. APAC Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 51. Europe Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 53. United States Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 54. Canada Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 57. China Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 58. Japan Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 59. Korea Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 61. India Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 62. Australia Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 63. Germany Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 64. France Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 65. UK Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 66. Italy Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 67. Russia Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 68. Spain Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 71. Israel Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Irritable Bowel Syndrome (IBS) Market Size 2021-2026 ($ Millions)
※본 조사보고서 [세계의 과민성 대장증후군 (IBS) 시장예측 2021년-2026년] (코드 : LPI-2201K00075) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 과민성 대장증후군 (IBS) 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!